Pfizer Inc. buy Guggenheim
Start price
11.12.24
/
50%
€24.08
Target price
11.12.25
€31.40
Performance (%)
-8.29%
End price
12.12.25
€22.08
Summary
This prediction ended on 12.12.25 with a price of €22.08. With a performance of -8.29%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. A total of €0.41 was paid as dividends for this prediction. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -3.766% | -3.766% | 3.267% |
| iShares Core DAX® | -1,36 % | -2,16 % | 2,08 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % | 32,60 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % | 58,27 % |
| iShares S&P 500 | -1,66 % | -0,70 % | 22,96 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Guggenheim from $35.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten